MY
MYND Life Sciences Inc.
MYNDF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $910.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 9.79x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 258.09%
Net margin 1,632.28%
Op. margin 1,966.62%
Quality
59 /100
Average ROIC 92.49%
ROA 190.32%
Asset turnover 0.12x
Debt
0 /100
High Current ratio 0.14x
Int. coverage -2.50x
Debt/Equity N/A
Stability
33 /100
Unstable Beta 0.98x
EPS volatility 2,768.25%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MYNDF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wilfred A. Jefferies
Employees
0
Headquarters
Port Coquitlam